BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity

Free Radical Biology and Medicine

Volumn 27, Issue 9-10, 1999, Pages 945-950

  Voehringer, David W ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Apoptosis; BCL 2; Channel Regulator; Free radicals; Gene expression; Glutathione; Glutathionylation

Indexed keywords

CASPASE; GLUTATHIONE; PROTEIN BCL 2; PROTEINASE;

APOPTOSIS; CONFERENCE PAPER; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BIOLOGICAL TRANSPORT, ACTIVE; CASPASES; ENDOPEPTIDASES; GENES, BCL-2; GLUTATHIONE; HUMANS; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 0033230015     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(99)00174-4     Document Type: Conference Paper

References (48)

1. Korsmeyer S.J. Bcl-2 initiates a new category of oncogenes regulators of cell death . Blood. 80:1992;879-886.
2. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
3. Veis D.J., Sorenson C.M., Shutter J.R., Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75:1993;229-240.
4. Hochman A., Sternin H., Gorodin S., Korsmeyer S., Ziv I., Melamed E., Offen D. Enhanced oxidative stress and altered antioxidants in brains of Bcl-2- deficient mice. J. Neurochem. 71:1998;741-748.
5. Gillardon F., Moll I., Meyer M., Michaelidis T.M. Alterations in cell death and cell cycle progression in the UV- irradiated epidermis of bcl-2-deficient mice. Cell Death Differ. 6:1999;55-60.
6. Muchmore S.W., Sattler M., Liang H., Meadows R.P., Harlan J.E., Yoon H.S., Nettesheim D., Chang B.S., Thompson C.B., Wong S.L., Ng S.L., Fesik S.W. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 381:1996;335-341.
7. Minn A.J., Velez P., Schendel S.L., Liang H., Muchmore S.W., Fesik S.W., Fill M., Thompson C.B. Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature. 385:1997;353-357.
8. Schendel S.L., Xie Z., Montal M.O., Matsuyama S., Montal M., Reed J.C. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA. 94:1997;5113-5118.
9. Susin S.A., Zamzami N., Kroemer G. Mitochondria as regulators of apoptosis doubt no more . Biochim. Biophys. Acta. 1366:1998;151-165.
10. Brenner C., Marzo I., Kroemer G. A revolution in apoptosis from a nucleocentric to a mitochondriocentric perspective . Exp. Gerontol. 33:1998;543-553.
11. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria a primary site for Bcl-2 regulation of apoptosis . Science. 275:1997;1132-1136.
12. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2 release of cytochrome c from mitochondria blocked . Science. 275:1997;1129-1132.
13. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:1999;441-446.
14. Garcia-Ruiz C., Colell A., Mari M., Morales A., Fernandez-Checa J.C. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J. Biol. Chem. 272:1997;11369-11377.
15. Marchetti P., Decaudin D., Macho A., Zamzami N., Hirsch T., Susin S.A., Kroemer G. Redox regulation of apoptosis impact of thiol oxidation status on mitochondrial function . Eur. J. Immunol. 27:1997;289-296.
16. Bornkamm G.W., Richter C. A link between the antioxidant defense system and calcium a proposal for the biochemical function of Bcl-2 . Curr. Top. Microbiol. Immunol. 194:1995;323-330.
17. Marin M.C., Fernandez A., Bick R.J., Brisbay S., Buja L.M., Snuggs M., McConkey D.J., von Eschenbach A.C., Keating M.J., McDonnell T.J. Apoptosis suppression by bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+. Oncogene. 12:1996;2259-2266.
18. Voehringer D.W., Story M.D., O'Neil R.G., Meyn R.E. Modulating Ca2+ in radiation-induced apoptosis suppresses DNA fragmentation but does not enhance clonogenic survival. Int. J. Radiat. Biol. 71:1997;237-243.
19. Herrmann J.L., Bruckheimer E., McDonnell T.J. Cell death signal transduction and Bcl-2 function. Biochem. Soc. Trans. 24:1996;1059-1065.
20. Mirkovic N., Voehringer D.W., Story M.D., McConkey D.J., McDonnell T.J., Meyn R.E. Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols. Oncogene. 15:1997;1461-1470.
21. Voehringer D.W., McConkey D.J., McDonnell T.J., Brisbay S., Meyn R.E. Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc. Natl. Acad. Sci. USA. 95:1998;2956-2960.
22. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesen D.E. Bcl-2 inhibition of neural death decreased generation of reactive oxygen species . Science. 262:1993;1274-1277.
23. Rimpler M.M., Rauen U., Schmidt T., Moroy T., de Groot H. Protection against hydrogen peroxide cytotoxicity in rat-1 fibroblasts provided by the oncoprotein Bcl-2 maintenance of calcium homoeostasis is secondary to the effect of Bcl-2 on cellular glutathione . Biochem. J. 340:1999;291-297.
24. Meredith M.J., Cusick C.L., Soltaninassab S., Sekhar K.S., Lu S., Freeman M.L. Expression of Bcl-2 increases intracellular glutathione by inhibiting methionine-dependent GSH efflux. Biochem. Biophys. Res. Commun. 248:1998;458-463.
25. Wright S.C., Wang H., Wei Q.S., Kinder D.H., Larrick J.W. Bcl-2-mediated resistance to apoptosis is associated with glutathione- induced inhibition of AP24 activation of nuclear DNA fragmentation. Cancer Res. 58:1998;5570-5576.
26. Papadopoulos M.C., Koumenis I.L., Xu L., Giffard R.G. Potentiation of murine astrocyte antioxidant defence by bcl-2:protection in part reflects elevated glutathione levels. Eur. J. Neurosci. 10:1998;1252-1260.
27. Ellerby L.M., Ellerby H.M., Park S.M., Holleran A.L., Murphy A.N., Fiskum G., Kane D.J., Testa M.P., Kayalar C., Bredesen D.E. Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J. Neurochem. 67:1996;1259-1267.
28. Bojes H.K., Datta K., Xu J., Chin A., Simonian P., Nunez G., Kehrer J.P. Bcl-xL overexpression attenuates glutathione depletion in FL5.12 cells following interleukin-3 withdrawal. Biochem. J. 325:1997;315-319.
29. Meister A. Glutathione metabolism and its selective modification. J. Biol. Chem. 263:1988;17205-17208.
30. Zheng M., Aslund F., Storz G. Activation of the OxyR transcription factor by reversible disulfide bond formation. Science. 279:1998;1718-1721.
31. Mannick J.B., Hausladen A., Liu L., Hess D.T., Zeng M., Miao Q.X., Kane L.S., Gow A.J., Stamler J.S. Fas-induced caspase denitrosylation. Science. 284:1999;651-654.
32. Davis D.A., Newcomb F.M., Starke D.W., Ott D.E., Mieyal J.J., Yarchoan R. Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J. Biol. Chem. 272:1997;25935-25940.
33. Sies H., Brigelius R., Graf P. Hormones, glutathione status and protein S-thiolation. Adv. Enzyme Regul. 26:1987;175-189.
34. van den Dobbelsteen D.J., Nobel C.S.I., Schlegel J., Cotgreave I.A., Orrenius S., Slater A.F. Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. J. Biol. Chem. 271:1996;15420-15427.
35. Ghibelli L., Fanelli C., Rotilio G., Lafavia E., Coppola S., Colussi C., Civitareale P., Ciriolo M.R. Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J. 12:1998;479-486.
36. Hampton M.B., Fadeel B., Orrenius S. Redox regulation of the caspases during apoptosis. Ann. NY Acad. Sci. 854:1998;328-335.
37. Herzenberg L.A., De Rosa S.C., Dubs J.G., Roederer M., Anderson M.T., Ela S.W., Deresinski S.C. Glutathione deficiency is associated with impaired survival in HIV disease. Proc. Natl. Acad. Sci. USA. 94:1997;1967-1972.
38. Aillet F., Masutani H., Elbim C., Raoul H., Chene L., Nugeyre M.T., Paya C., Barre-Sinoussi F., Gougerot-Pocidalo M.A., Israel N. Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T- or monocytic cell lines. J. Virol. 72:1998;9698-9705.
39. Li J., Billiar T.R., Talanian R.V., Kim Y.M. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem. Biophys. Res. Commun. 240:1997;419-424.
40. Mannick J.B., Hausladen A., Liu L., Hess D.T., Zeng M., Miao Q.X., Kane L.S., Gow A.J., Stamler J.S. Fas-induced caspase denitrosylation. Science. 284:1999;651-654.
41. Kim Y.M., Talanian R.V., Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3- like activity via two distinct mechanisms. J. Biol. Chem. 272:1997;31138-31148.
42. Fiorucci S., Antonelli E., Santucci L., Morelli O., Miglietti M., Federici B., Mannucci R., Del Soldato P., Morelli A. Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology. 116:1999;1089-1106.
43. Fiorucci S., Santucci L., Federici B., Antonelli E., Distrutti E., Morelli O., Renzo G.D., Coata G., Cirino G., Soldato P.D., Morelli A. Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha. Aliment Pharmacol. Ther. 13:1999;421-435.
44. Toledano M.B., Kullik I., Trinh F., Baird P.T., Schneider T.D., Storz G. Redox-dependent shift of OxyR-DNA contacts along an extended DNA- binding site a mechanism for differential promoter selection . Cell. 78:1994;897-909.
45. Sun Y., Oberley L.W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21:1996;335-348.
46. Hainaut P., Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 53:1993;4469-4473.
47. Rainwater R., Parks D., Anderson M.E., Tegtmeyer P., Mann K. Role of cysteine residues in regulation of p53 function. Mol. Cell Biol. 15:1995;3892-3903.
48. Shimizu S., Narita M., Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 399:1999;483-487.